Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUTOGRAFTIM: Intramuscular Islet Autograft After Pancreatectomy
NCT02872571Phase 2Active, not recruiting
- Sponsor
- CHU de Lille
- Start
- Mar 2013
- Primary completion
- Apr 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Intramuscular Islet Autograft in endocrine pancreas disorder, sponsored by CHU de Lille. Started Mar 2013; status: active, not recruiting.
02
Drugs
Intramuscular Islet Autograft
03
Conditions
endocrine pancreas disorder
Beyond the preview
Go deeper on NCT02872571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872571.